S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
Log in

NASDAQ:APYX - Apyx Medical Stock Price, Forecast & News

$3.49
-0.10 (-2.79 %)
(As of 04/1/2020 04:00 PM ET)
Today's Range
$3.34
Now: $3.49
$3.55
50-Day Range
$3.24
MA: $5.88
$8.02
52-Week Range
$2.92
Now: $3.49
$8.59
Volume160,515 shs
Average Volume95,224 shs
Market Capitalization$119.25 million
P/E RatioN/A
Dividend YieldN/A
Beta0.46
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Read More

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APYX
CUSIPN/A
CIKN/A
Phone727-384-2323

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$28.15 million
Book Value$2.64 per share

Profitability

Net Income$-19,650,000.00

Miscellaneous

Employees222
Market Cap$119.25 million
Next Earnings Date5/13/2020 (Estimated)
OptionableOptionable

Receive APYX News and Ratings via Email

Sign-up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter.


Apyx Medical (NASDAQ:APYX) Frequently Asked Questions

How has Apyx Medical's stock been impacted by COVID-19 (Coronavirus)?

Apyx Medical's stock was trading at $5.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, APYX stock has decreased by 31.0% and is now trading at $3.49. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Apyx Medical?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Apyx Medical.

When is Apyx Medical's next earnings date?

Apyx Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Apyx Medical.

How were Apyx Medical's earnings last quarter?

Apyx Medical Corp (NASDAQ:APYX) released its quarterly earnings results on Monday, March, 16th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.19) by $0.03. The firm had revenue of $8.38 million for the quarter. Apyx Medical had a negative return on equity of 23.33% and a negative net margin of 66.19%. View Apyx Medical's earnings history.

What guidance has Apyx Medical issued on next quarter's earnings?

Apyx Medical issued an update on its first quarter 2020 After-Hours earnings guidance on Monday, March, 16th. The company provided EPS guidance of for the period. The company issued revenue guidance of $5-5.6 million, compared to the consensus revenue estimate of $7.82 million.

What price target have analysts set for APYX?

3 brokers have issued 1 year price objectives for Apyx Medical's shares. Their forecasts range from $7.00 to $10.00. On average, they anticipate Apyx Medical's stock price to reach $8.50 in the next year. This suggests a possible upside of 143.6% from the stock's current price. View analysts' price targets for Apyx Medical.

Has Apyx Medical been receiving favorable news coverage?

Media coverage about APYX stock has trended neutral recently, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Apyx Medical earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutApyx Medical.

Are investors shorting Apyx Medical?

Apyx Medical saw a decrease in short interest in the month of March. As of March 13th, there was short interest totaling 957,200 shares, a decrease of 5.2% from the February 27th total of 1,010,000 shares. Based on an average trading volume of 86,600 shares, the days-to-cover ratio is presently 11.1 days. Approximately 3.2% of the company's shares are short sold. View Apyx Medical's Current Options Chain.

Who are some of Apyx Medical's key competitors?

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), Wells Fargo & Co (WFC), Amgen (AMGN), Broadcom (AVGO), Corbus Pharmaceuticals (CRBP), Kraft Heinz (KHC) and Walgreens Boots Alliance (WBA).

Who are Apyx Medical's key executives?

Apyx Medical's management team includes the following people:
  • Mr. Charles D. Goodwin II, Pres, CEO & Director (Age 53)
  • Ms. Tara H. Semb, CFO, Treasurer & Sec. (Age 49)
  • Mr. Moshe Citronowicz, Sr. VP (Age 66)
  • Mr. Todd Hornsby, Exec. VP (Age 43)

What is Apyx Medical's stock symbol?

Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."

How do I buy shares of Apyx Medical?

Shares of APYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Apyx Medical's stock price today?

One share of APYX stock can currently be purchased for approximately $3.49.

How big of a company is Apyx Medical?

Apyx Medical has a market capitalization of $119.25 million and generates $28.15 million in revenue each year. The company earns $-19,650,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis. Apyx Medical employs 222 workers across the globe. View additional information about Apyx Medical.

What is Apyx Medical's official website?

The official website for Apyx Medical is http://www.apyxmedical.com/.

How can I contact Apyx Medical?

Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The company can be reached via phone at 727-384-2323 or via email at [email protected]


MarketBeat Community Rating for Apyx Medical (NASDAQ APYX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  45 (Vote Underperform)
Total Votes:  90
MarketBeat's community ratings are surveys of what our community members think about Apyx Medical and other stocks. Vote "Outperform" if you believe APYX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APYX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel